United States - English - NLM (National Library of Medicine)

allermed laboratories, inc. - mucor plumbeus (unii: d7401pwy6e) (mucor plumbeus - unii:d7401pwy6e) - mucor plumbeus 0.1 g in 1 ml - allergenic extract may be used as a diagnostic skin test reagent in persons suspected of being sensitive to the allergenic source material from which the extract is made. skin tests should be used in conjunction with a thorough allergic history to establish the relevance of a given allergen in the etiology of allergic disease. 4,5,6 immunotherapy with allergenic extract is indicated in persons suffering from allergic rhinitis, bronchitis, conjunctivitis, urticaria and asthma. the therapeutic efficacy of allergenic extract has been proven in ragweed, grass, and mountain cedar pollinosis, cat-induced asthma and hypersensitivity to hymenoptera venoms. 7-12 immunotherapy may be used along with or exclusive of antihistamines and other medications used to control allergic symptoms. allergenic extract should not be administered to a non-allergic person. however, there are no absolute contraindications to the use of allergenic extract for treatment in appropriate individuals. relative contraindications in

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

averroes pharmaceuticals sdn. bhd. - betamethasone dipropionate -

United States - English - NLM (National Library of Medicine)

bioactive nutritional, inc. - echinacea purpurea whole (unii: qi7g114y98) (echinacea purpurea - unii:qi7g114y98), goldenseal (unii: zw3z11d0jv) (goldenseal - unii:zw3z11d0jv), eupatorium perfoliatum flowering top (unii: 1w0775vx6e) (eupatorium perfoliatum flowering top - unii:1w0775vx6e), verbascum thapsus whole (unii: c9td27u172) (verbascum thapsus - unii:c9td27u172), ailanthus altissima flowering twig (unii: 8p29o5p7xu) (ailanthus altissima flowering twig - unii:8p29o5p7xu), onion (unii: 492225q21h) (onion - unii:492225q21h), am - for temporary relief of coryza, sneezing, water discharge. stuffed up feeling of nose and head. eyes red with much burning. hoarseness and cough with soreness in the chest. for temporary relief of coryza, sneezing, water discharge. stuffed up feeling of nose and head. eyes red with much burning. hoarseness and cough with soreness in the chest.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

sideritus angustifolia 15% quassia amora 35%, alnus glutinosa 20%. chionantus virginica 30%

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

zanthoxylum zanthoxyloides 325,vicia faba 18%,alchornea cordifolia 14%,alnus glutinosa 14%

New Zealand - English - Ministry for Primary Industries

upl new zealand limited - triclopyr - triclopyr 120 g/litre - herbicide

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - house dust (unii: eyo007vx98) (house dust - unii:eyo007vx98) - house dust 10000 [pnu] in 1 ml - these products are for diagnostic use only. diagnostic allergenic extracts are indicated for use in skin testing to establish the clinical relevance of specific allergens to which the patient has been exposed. by measuring skin test response, the physician may assess the degree of sensitivity that patients have to the allergens. for extracts standardized in au and bau, see individual directions for use. allergenic extracts for diagnostic use only of coffee, mosquito, cottonseed, and flaxseed have not been shown by adequate data to be safe and effective for therapeutic use. patients on beta blockers can be non-responsive to beta agonists that may be required to reverse a systemic reaction (also, see boxed warning statement and adverse reactions ). the physician should carefully weigh the benefit derived from skin testing vs. the risk to the patient should a systemic reaction arise. patients with unstable asthma or steroid dependent asthmatics and patients with underlying cardiovascular disease are at greater

United States - English - NLM (National Library of Medicine)

jubilant hollisterstier llc - sorghum halepense pollen (unii: 577va5b4hp) (sorghum halepense pollen - unii:577va5b4hp) - sorghum halepense pollen 0.1 g in 1 ml - allergenic extracts are indicated for use in diagnosis and immunotherapy of patients presenting symptoms of allergy (hay fever, rhinitis, etc.) to specific environmental allergens. the selection of allergenic extracts to be used should be based on a thorough and carefully taken history of hypersensitivity, and confirmed by skin testing. the use of mixed or unrelated antigens for skin testing is not recommended since, in the case of a positive reaction, it does not indicate which component of the mix is responsible for the reaction, while, in the case of a negative reaction, it fails to indicate whether the individual antigens at full concentration would give a positive reaction. utilization of such mixes for compounding a treatment may result, in the former case, in administering unnecessary antigens and, in the latter case, in the omission of a needed antigen. avoidance of allergens is to be advocated if possible, but cannot always be attained, e.g., allergy to dog dander in kennel owners and employees,

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - aspergillus niger var. niger (unii: 9ioa40ang6) (aspergillus niger var. niger - unii:9ioa40ang6), aspergillus repens (unii: sq89e6lome) (aspergillus repens - unii:sq89e6lome), aspergillus flavus var. oryzae (unii: q6z8uk5r3g) (aspergillus flavus var. oryzae - unii:q6z8uk5r3g), aspergillus terreus (unii: qbn8k7055x) (aspergillus terreus - unii:qbn8k7055x) - gibberella zeae 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust, molds, animal danders, various other inhalants, and in situations where the offending allergen cannot be avoided. prior to initiation of therapy, the clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms, ige antibodies, positive skin tests, or properly controlled challenge testing. in most cases, immunotherapy is not indicated for those allergens that can be eliminated or minimized by environmental control. patients on beta-blockers are not candidates for immunotherapy, as they can be non-responsive to beta-agonists that may be required to reverse a systemic reaction (also see warnings and adverse

United States - English - NLM (National Library of Medicine)

alk-abello, inc. - solidago canadensis pollen (unii: 644cz16ir5) (solidago canadensis pollen - unii:644cz16ir5) - equus caballus skin 20000 [pnu] in 1 ml - hyposensitization (injection) therapy is a treatment for patients exhibiting allergic reactions to seasonal pollens, dust, molds, animal danders, various other inhalants, and in situations where the offending allergen cannot be avoided. prior to initiation of therapy, the clinical sensitivity should be established by careful evaluation of the patient’s history confirmed by diagnostic skin testing. hyposensitization should not be prescribed for sensitivities to allergens which can easily be avoided. a patient should not be immunized with preparations of allergens to which the patient has not demonstrated symptoms, ige antibodies, positive skin tests, or properly controlled challenge testing. in most cases, immunotherapy is not indicated for those allergens that can be eliminated or minimized by environmental control. patients on beta-blockers are not candidates for immunotherapy, as they can be non-responsive to beta-agonists that may be required to reverse a systemic reaction (also see warnings and adverse